Understanding Cellular and Molecular Responses in the Treatment of Pediatric Lymphatic Anomalies

    Maria Gnarra, C. Shad, Elidona Mirashi, Ajit Muley, Connie H. Keung, Muredach P Reilly, Jianguo Wu, CJ Shawber
    New to Rapamycin? There is a guide in the encyclopedia. Read the guide →
    Image
    Studysummary This study suggests that sirolimus and propranolol may reduce abnormal lymphatic endothelial cell proliferation in lymphatic malformations, potentially improving vessel function and patient outcomes.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Discuss this study in the Community →